[Apropos of the clinical use of the long-acting betamethasone preparation (celestone chronodose) in ophtalmology].
D000328:Adult; D001623:Betamethasone / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D009877:Endophthalmitis / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy*; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D007634:Keratitis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009184:Mydriatics / Q000008:administration & dosage*; D009902:Optic Neuritis / Q000188:drug therapy; D012173:Retinitis / Q000188:drug therapy; D012590:Sclera; D014456:Ulcer / Q000188:drug therapy; D014605:Uveitis / Q000188:drug therapy
D003692:Delayed-Action Preparations; D005938:Glucocorticoids; D009184:Mydriatics; D001623:Betamethasone
A propos de l'emploi clinique de la forme retard de la bétaméthasone (célestone chronodose) en ophtalmologie.